Performance Outcomes: Measure & Metric Details

Similar documents
MSPPS Clinical Focus Areas

Key Behavioral Health Measures (18 Years and Older)

Hedis Behavioral Health Measures

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES

LRE Executive Dashboard Integrated Care Delivery Platform (ICDP)

KEY BEHAVIORAL MEASURES

Key Behavioral Measures (17 Years and Younger)

Quality measures desktop reference for Medicaid providers

Quality measures desktop reference for Medicaid providers

Quality measures desktop reference for Medicaid providers

Quality measures desktop reference for Medicaid providers

SUMMARY TABLE OF MEASURE CHANGES

HEDIS 2017 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING

th Street, NW Suite 1000 Washington, DC phone fax

KEY BEHAVIORAL MEASURES

November Data Jam. Mastering PSYCKES: Maximizing Multiple Data Sources to Operationalize a Population Health Approach

Exhibit I-1 Performance Measures. Numerator (general description only)

HEDIS 2014 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING

HEDIS/QARR 2018 Quick Reference Guide ALL MEASURES

Changes for Physician Measurement 2018

MEASURING CARE QUALITY

th Street, NW Suite 1000 Washington, DC phone fax

2016 General Practice/Family Practice Preferred Specialty Measure Set

PCMH 2018 Enrollment and Update August 25, 2017

2017 HEDIS Measures. PREVENTIVE SCREENING 2017 Measure Quality Indicator

Quality Care Plus 2015 Primary Care Physician Incentive Program. Now includes Medicare patients!

Quality Measures Desktop Reference for Medicaid Providers

QUALITY IMPROVEMENT Section 9

HEDIS 2015 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING

Appendix 4: Summary of Recommended Changes to HEDIS/CAHPS Measure List

RCCO Quality Indicators Crosswalk

2016 Internal Medicine Preferred Specialty Measure Set

Cardiovascular Health and Diabetes Screening for People with Schizophrenia

Jan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X

Michigan Quality Improvement Consortium Measurement Specifications

Adult HEDIS & STARs Measures

For Electronic Measure Specification Information go to:

Arkansas Blue Cross and Blue Shield (ABCBS) Patient Centered Medical Home (PCMH) Specifications Manual

Clinical Quality Measures

AMCP Webinar Series. Exchanges and Qualified Health Plans: How your voice can shape the future of quality reporting 14 January 2014.

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

Meaningful Use Clinical Quality Measures for Eligible Professionals

Texas Council Endorsed Measurement Strategy

Achieving Quality and Value in Chronic Care Management

CLINICAL QUALITY MEASURES Stage 1 Meaningful Use

Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists

Introducing ValueOptions Clinical Care Alerts

Adult-Peds Quality Measure Information Sheet 2018

JAWDA Performance Quarterly KPI Profile (Clinic & Centers) March 2018

Comprehensive ESRD Care (CEC) Model Proposed Quality Measures for Public Comment. Table of Contents

Clinical Quality Measures for Submission by Medicare or Medicaid EP/s for the 2011 and 2012 Payment Year

HEDIS/QARR 2017 Quick Reference Guide ALL MEASURES

HEALTHCARE REFORM. September 2012

Collecting and Using Data to Improve Consumer Health Outcomes

American College of Physicians Genesis Registry

Michigan Quality Improvement Consortium Measurement Specifications

CY 2017 MMA Performance Measure Scores HEDIS, Core Set, and Agency-defined measures

Behavioral Health Phase 1, 2012

Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings

WCHQ MEASURES AT A GLANCE

HEDIS/CAHPS 101 August 13, 2012 Minnesota Measurement and Reporting Workgroup

NQF Measure Number & PQRI Implementation Number

MEASURES AND QUALITY IMPROVEMENT

2017 MSSP Clinical Quality Measures

American College of Physicians Genesis Registry

MEASURING CARE QUALITY

Quality Payment Program: Cardiology Specialty Measure Set

Michigan Quality Improvement Consortium Detailed Measurement Specifications HEDIS 2014 (measurement year 2013)

Disease Management. Measures At A Glance

Clinical Quality Measures - Colorado SIM, TCPI

NQF Behavioral Health Project Phase II Submitted Measures

WCHQ MEASURES AT A GLANCE

Title: NCQA HEDIS Health Plan Measures

Clinical Integration Quality Measures

QBPC Claims Based Provider Quick Reference Guide

2018 MIPS Reporting Family Medicine

Michigan Quality Improvement Consortium Detailed Measurement Specifications HEDIS 2015 (measurement year 2014)

HUSKY Health Benefits and Prior Authorization Requirements Grid* Behavioral Health Partnership Effective: January 1, 2012

Provider Perspective of Quality Measurement

PQS Summary of Pharmacy/ Medication-Related Updates in the CY 2020 Final Call Letter

2016 Medicaid Adult CAHPS 5.0H. At-A-Glance Report

Meaningful Use for Eligible Providers

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

2019 HEDIS 1 Measures Healthcare Effectiveness Data and Information Set

2016 HEDIS Measures and Specifications

NYP Queens PPS PAC Meeting. March 19, 2018

HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

2018 HEDIS 1 Measures Healthcare Effectiveness Data and Information Set

emeasure Titles and Descriptions

Quality Payment Program: Cardiology Specialty Measure Set

ABCBS PCMH Specifications. ARKANSAS BLUE CROSS and BLUE SHIELD An Independent Licensee of the Blue Cross and Blue Shield Association

Validating and Reporting the 2017 ACO Clinical Measures (Version 1)

NCQA Health Insurance Plan Ratings Methodology March 2019

QUALITY RATING SYSTEM: BACKGROUND

Transcription:

Performance Outcomes: Measure & Metric Details Adherence to Antipsychotic Medications for People with Schizophrenia Numerator: Number of people who remained on an antipsychotic for at least 80% of their treatment period Denominator: Number of people ages 19 to 64 with Schizophrenia who were dispensed at least 2 antipsychotic s during the MY Adult Access to Preventative or Ambulatory Care 20 to 44 Denominator: Number of adults ages 20 44 as of June 30 MY Adult Access to Preventative or Ambulatory Care 45 to 64 Denominator: Number of adults ages 45 64 as of June 30 MY Adult Access to Preventative or Ambulatory Care 65 and older Denominator: Number of adults ages 65 and older as of June 30 MY Antidepressant Medication Management Effective Acute Phase Treatment Numerator: Number of people who remained on antidepressant during the entire 12 week acute treatment phase Denominator: Number of people 18 and older who were diagnosed with depression and treated with antidepressant Antidepressant Medication Management Effective Continuation Phase Treatment Numerator: Number of people who remained on antidepressant for at least 6 months Denominator: Number of people 18 and older who were diagnosed with depression and treated with antidepressant Aspirin Use Numerator: Number of respondents who are currently taking aspirin daily or every other day Denominator: Number of respondents who are men, ages 46 to 65 years with at least one cardiovascular risk factor; men, ages 66 to 79, regardless or risk factors and women ages 56 to 79 with at least 2 cardiovascular risk factors Cardiovascular Monitoring for people with Cardiovascular Disease and Schizophrenia Numerator: Number of people who had a LDL C test during the Measurement Year Denominator: Number of people ages 18 to 64 years with schizophrenia and cardiovascular disease Care Coordination (Q13, 17 and 20) Numerator: Number responses Usually or Always that provider seemed to know important history, follow up to give results from tests, and talked about all prescription medicines Denominator: All responses

Children's Access to Primary Care 12 to 24 months Denominator: Number of children ages 12 to 24 months as of June 30 MY Children's Access to Primary Care 25 months to 6 years Denominator: Number of children ages 25 months to 6 years as of June 30 MY Children's Access to Primary Care 7 to 11 years Denominator: Number of children ages 7 to 11 years as of June 30 MY Children's Access to Primary Care 12 to 19 years Denominator: Number of children ages 12 to 19 years as of June 30 MY Controlling High Blood Pressure Numerator: Number of people whose blood pressure was adequately controlled as follows: below 140/90 if ages 18 59; below 140/90 for ages 60 to 85 with a diabetes diagnosis; or below 150/90 ages 60 to 85 without a diagnosis of diabetes Denominator: Number of people ages 18 to 85, who have hypertension Diabetes Monitoring for People with Diabetes and Schizophrenia Numerator: Number of people who had both an LDL C test and an HbA1c test during the Measurement Year Denominator: Number of people ages 18 to 64 with schizophrenia and diabetes Diabetes Screening for people with Schizophrenia or Bipolar Disease who are using Antipsychotic Medication Numerator: Number of people who had a diabetes screening test during the Measurement Year Denominator: Number of people ages 18 to 64 years with Schizophrenia or Bipolar Disorder who were dispensed an antipsychotic Discussion of Risks and Benefits of Aspirin Use Numerator: Number of respondents who discussed risks and benefits of using aspirin with a doctor or health provider Denominator: Number of respondents who are men, ages 46 to 79 years old and women who are 56 to 79 years old ED Use by Uninsured Numerator: The percentage of ED visits which are self pay payer typology only for all hospitals in the PPS network in the Measurement Year Denominator: The percentage of ED visits for self pay payer typology only for all hospitals in the PPS network in the baseline Measurement Year Engagement of Alcohol or Other Drug Dependence Treatment (Initiation and 2 visits within 44 days) Numerator: Number of people who initiated treatment AND who has two or more additional services with a diagnosis of AOD within 30 days of the initiation visit Denominator: Number of people age 13 and older with a new episode of AOD dependence

Flu Shots for Adults Ages 18 64 Numerator: Number of respondents who have had a flu shot Denominator: Number of respondents, ages 18 to 64 years Follow up After Hospitalization for Mental Illness within 7 days Numerator: Number of discharges where the patient was seen on an ambulatory basis or who was in intermediate treatment with a mental health provider within 7 days of discharge Denominator: Number of discharges between the start of the measurement period to 30 days before the end of the measurement period for patients ages 6 years and older who were hospitalized for treatment of selected mental health disorders Follow up After Hospitalization for Mental Illness within 30 Days Numerator: Number of discharges where the patient was seen on an ambulatory basis or who was in intermediate treatment with a mental health provider within 30 days of discharge Denominator: Number of discharges between the start of the measurement period to 30 days before the end of the measurement period for patients ages 6 years and older who were hospitalized for treatment of selected mental health disorders Follow up Care for Children prescribed ADHD Medications Initiation Phase Numerator: Number of children who had one follow up visit with a practitioner within the 30 days after starting the Denominator: Number of children ages 6 to 12 years who were newly prescribed ADHD. Follow up Care for Children Prescribed ADHD Medications Continuation Phase Numerator: Number of children who in addition to the visit in the initiation phase had at least 2 follow up visits in the 9 month period after the initiation phase ended Denominator: Number of children ages 6 to 12 years old who were newly prescribed ADHD and remained on the for 7 months Getting Timely Appointments, Care and Information (Q6, Q8 and Q10) Numerator: Number of responses "Usually" or "Always" got appointment for urgent care or routine care as soon as needed, got answers the same day if called during the day Denominator: Number who answered they called for appointments or called for information HCAHPS Care Transition Metrics (Q23, Q24 and Q25) Numerator: Average of hospital specific results for the Care Transition composite using Strongly Agree and Agree Responses Denominator: Hospitals with HCAHPS participating in the PPS network Health Literacy Instructions Easy to Understand (QHL13) Numerator: Number responses Usually or Always that instructions for caring for condition were easy to understand Denominator: Number who answered they saw provider for an illness or condition and were given instructions Health Literacy Describing How to Follow Instructions (QHL14) Numerator: Number responses Usually or Always that provider asked patient to describe how the instruction would be followed Denominator: Number of respondents who answered they saw provider for an illness or condition and were given instructions

Health Literacy Explained What to do if Illness Got Worse (QHL16) Numerator: Number responses Usually or Always that provider explained what to do if illness/condition got worse or came back Denominator: Number who answered they saw provider for an illness or condition Initiation of Alcohol & Other Drug Dependence Treatment (1 visit w/in 14 days) Numerator: Number of people who initiated treatment through an inpatient AOD admission, outpatient visit, intensive outpatient encounter or partial hospitalization within 14 days of the index episode Denominator: Number of people age 13 and older with a new episode of AOD dependence Medical Assistance with Smoking and Tobacco Use Cessation Advised to Quit Numerator: Number of responses "Sometimes", "Usually" or "Always" were advised to quit Denominator: Number of respondents, ages 18 and older, who smoke or use tobacco some days or every day Medical Assistance with Smoking and Tobacco Use Cessation Discussed Cessation Medication Numerator: Number of responses "Sometimes", "Usually" or "Always" discussed cessation Medications Denominator: Number of respondents, ages 18 and older who smoke or use tobacco some days or every day Medical Assistance with Smoking and Tobacco Use Cessation Discussed Cessation Strategies Numerator: Number of responses "Sometimes", "Usually" or "Always" discussed cessation methods or strategies Denominator: Number of respondents, ages 18 and older who smoke or use tobacco some days or every day Non use of Primary Care and Preventive Care Services Numerator: The percentage of Medicaid members who do not have at least one claim with a preventive services CPT or equivalent code in the Measurement Year Denominator: The percentage of Medicaid members who do not have at least one claim with a preventive services CPT or equivalent code in the baseline Measurement Year Pediatric Quality Indicators (PDI) 90 Composite of All Measures Numerator: Number of admissions which were in the numerator of one of the pediatric prevention quality indicators Denominator: Number of people 6 to 17 years as of June 30 MY Potentially Preventable Emergency Department Visits (for persons with BH diagnosis) Numerator: Number of preventable emergency visits as defined by revenue and CPT codes Denominator: Number of people with a BH diagnosis (excludes those born during the Measurement Year) as of June 30 of Measurement Year Potentially Preventable Emergency Room Visits Numerator: Number of preventable emergency visits as defined by revenue and CPT codes Denominator: Number of people (excludes those born during the Measurement Year) as of June 30 of Measurement Year Potentially Avoidable Readmissions Numerator: Number of readmissions chains (at risk admissions followed by one or more clinically related readmissions within 30 days of discharge) Denominator: Number of people as of June 30

Prevention Quality Indicator # 7 (Hypertension) Numerator: Number of admissions with a principal diagnosis of hypertension Prevention Quality Indicator # 8 (Heart Failure) Numerator: Number of admissions with a principal diagnosis of heart failure Primary Care Length of Relationship Q3 Numerator: Percentage of responses for at least 1 year or longer Denominator: All Responses Primary Care Usual Source of Care Q2 Numerator: Percent of Responses "Yes" Denominator: All Responses Prevention Quality Indicator (PQI) 90 Composite of all Measures Numerator: Number of admissions which were in the numerator of one of the adult prevention quality indicators Screening for Clinical Depression and Follow Up Numerator: Number of people screened for clinical depression using a standardized depression screening tool and if positive, with follow up within 30 days Denominator: Number of people with a qualifying outpatient visit who are 18 and older Statin Therapy for Patients with Cardiovascular Disease Received Statin Therapy Numerator: Number of people who were dispensed at least one high or moderate intensity statin Denominator: Number of males age 21 to 75 or females age 40 to 75 who have had an MI, CABG or PCI in the year prior or a diagnosis of ischemic vascular disease in both the Measurement Year and year prior Statin Therapy for Patients with Cardiovascular Disease Statin Adherence 80% Numerator: Number of people who achieved a proportion of days covered of 80% for the treatment period Denominator: Number of males age 21 to 75 or females age 40 to 75 who have had an MI, CABG or PCI in the year prior or a diagnosis of ischemic vascular disease in both the Measurement Year and year prior AND who were dispensed at least one high or moderate intensity statin